CSAR Subsidiary Regulations: China to Implement the Strictest Cosmetic Sampling Testing Regulation
In September 2020 and June 2022, China National Medical Products Administration (NMPA) issued two drafts of Measures for the Management of Cosmetic Sampling Testing. Finally, on January 12, 2023, NMPA released the finalized Measures, which will be implemented on March 1, 2023.
The Measures is divided into 8 chapters and 61 articles, providing detailed requirements on the formulation of sampling testing work plan, sampling, testing and result submission, objection and re-testing, verification and disposal of unqualified products, as well as information disclosure. The key points are summarized and analyzed as follows.
EU SCCS Consults on Opinion as to Hydroxyapatite (nano)
On January 11, 2023, EU Scientific Committee on Consumer Safety (SCCS) released the preliminary opinion SCCS/1648/22 on Hydroxyapatite (CAS No. 1306-06-17) in nano form. The opinion is open for comments until March 1, 2023.
